Inaugural conversation with Dr. Joe Galati and Dr. Mazen Noureddin: a high-level, clinically focused primer on fatty liver disease (MASLD), metabolic syndrome, and why this constellation of conditions represents a growing public‑health threat.

Both Dr. Galati and Dr. Noureddin are experts in liver disease and clinical research, bringing clinical perspective and trial experience to the discussion.

Geared to clinicians, advanced practice providers, researchers, and trial designers, we unpack new terminology and diagnostic framing for fatty liver, summarize current FDA‑approved drug therapies and promising agents in the development pipeline, and explain how evolving treatments fit into clinical practice and trial design.

Drs. Galati and Noureddin map the multidisciplinary “mosaic” of care—awareness and prevention, screening and diagnostics, lifestyle and metabolic management, and targeted therapeutic interventions—illustrating practical approaches for integrating these components to improve patient outcomes.

Listen for actionable insights on diagnosis, treatment planning, and the future of MASLD research and therapeutics.

Thank you for listening to The Metabolic Mosaic! We value your feedback and would love to hear your ideas for future topics and guests.

For general inquiries, please email us at info@themetabolicmosaic.com.

To learn more about Dr. Joe Galati and his work, visit his website You can connect with Dr. Mazen Noureddin hear and learn more about his clinic research initiatives.

Your engagement helps us create content that matters to you, and we appreciate your continued support of the show.

Hosted on Acast. See acast.com/privacy for more information.